A review in JAMA Neurology concluded that clinicians should monitor patients with COVID-19 for neurological disorders, but more research is needed to further examine the role of SARS-CoV-2 as a contributor to postinfectious neurologic complications, one of the review’s authors told Healio Primary Care.
“The biggest issue and recurring theme regarding neurologic manifestations in patients with COVID-19 is that we understand very little about them,” Serena Spudich, MD, MA, division chief of neurological infections and global neurology at Yale University School of Medicine, said
Uncategorized